全文获取类型
收费全文 | 2521篇 |
免费 | 121篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 38篇 |
妇产科学 | 28篇 |
基础医学 | 260篇 |
口腔科学 | 31篇 |
临床医学 | 156篇 |
内科学 | 902篇 |
皮肤病学 | 29篇 |
神经病学 | 158篇 |
特种医学 | 180篇 |
外科学 | 393篇 |
综合类 | 12篇 |
预防医学 | 65篇 |
眼科学 | 36篇 |
药学 | 103篇 |
中国医学 | 3篇 |
肿瘤学 | 244篇 |
出版年
2023年 | 21篇 |
2022年 | 33篇 |
2021年 | 89篇 |
2020年 | 45篇 |
2019年 | 52篇 |
2018年 | 53篇 |
2017年 | 58篇 |
2016年 | 56篇 |
2015年 | 58篇 |
2014年 | 83篇 |
2013年 | 97篇 |
2012年 | 156篇 |
2011年 | 173篇 |
2010年 | 115篇 |
2009年 | 58篇 |
2008年 | 164篇 |
2007年 | 149篇 |
2006年 | 161篇 |
2005年 | 160篇 |
2004年 | 172篇 |
2003年 | 148篇 |
2002年 | 129篇 |
2001年 | 48篇 |
2000年 | 34篇 |
1999年 | 56篇 |
1998年 | 41篇 |
1997年 | 30篇 |
1996年 | 23篇 |
1995年 | 10篇 |
1994年 | 22篇 |
1993年 | 8篇 |
1992年 | 19篇 |
1991年 | 12篇 |
1990年 | 12篇 |
1989年 | 14篇 |
1988年 | 8篇 |
1987年 | 13篇 |
1986年 | 8篇 |
1985年 | 10篇 |
1984年 | 10篇 |
1983年 | 10篇 |
1980年 | 4篇 |
1978年 | 3篇 |
1977年 | 6篇 |
1976年 | 3篇 |
1970年 | 2篇 |
1969年 | 5篇 |
1968年 | 2篇 |
1967年 | 2篇 |
1966年 | 2篇 |
排序方式: 共有2662条查询结果,搜索用时 15 毫秒
31.
Total Esophagectomy versus Proximal Esophagectomy for Esophageal Cancer at the Cervicothoracic Junction 总被引:1,自引:0,他引:1
Fujita H Kakegawa T Yamana H Sueyoshi S Hikita S Mine T Tanaka Y Ishikawa H Shirouzu K Mori K Inoue Y Tanabe HY Kiyokawa K Tai Y Inutsuka H 《World journal of surgery》1999,23(5):486-491
To investigate the adequate extent of esophagectomy and lymphadenectomy for an esophageal cancer localized at the cervicothoracic
junction, the mortality and morbidity rates, survival rates, and patterns of recurrence were retrospectively analyzed in two
groups—14 patients who underwent total esophagectomy with or without laryngectomy and 15 patients who underwent proximal esophagectomy
with or without laryngectomy—at Kurume University Hospital from 1981 to 1996. Proximal esophagectomy with or without laryngectomy
resulted in a lower hospital mortality rate and better overall survival for patients who underwent curative esophagectomy
compared with total esophagectomy with or without laryngectomy. Multivariate analysis indicated that the extent of esophagectomy
(total esophagectomy versus proximal esophagectomy) was not a prognostic factor. The incidence of recurrence was not different
between the two groups. Lymph node metastasis or recurrence from such esophageal cancers was localized to the neck and upper
mediastinum. For an esophageal cancer localized at the cervicothoracic junction, therefore, proximal esophagectomy with or
without laryngectomy and with cervical and upper mediastinal lymphadenectomy could be better indicated for preselected patients. 相似文献
32.
Ryoichi Sato Ichiro Hisatome Yasunori Tanaka Norito Sasaki Hiroshi Kotake Hiroto Mashiba Ryo Katori 《Naunyn-Schmiedeberg's archives of pharmacology》1991,344(3):331-336
Summary Aprindine is a class Ib antiarrhythmic agent. We studied effects of aprindine (3 µmol/l) on the Na+ current using whole cell voltage clamp (tip resistance = 0.5 , [Na]i ando = 10 mmol/l at 18°C). Aprindine revealed tonic block (Kdrest = 37.7 µmol/l, Kdi = 0.74 µmol/l; n = 4). Aprindine, shifted inactivation curve to hyperpolarizing direction by 11.4 ± 3.5 mV (n = 4) without changes in slope factor. In the presence of 3 µmol/l aprindine, aprindine showed phasic block, i.e., duration-dependent block at 2 Hz (64% ±3070 at 1.5 ms, 82%±6% at 20 ms, 93%±7% at 200 ms; n = 4). Short single prepulse also produced aprindine-induced phasic block (12% at 1.5 ms, 22% at 100 ms; n = 2). After removal of fast inactivation of Na+ current by 3 mmol/l tosylchloramide sodium, aprindine revealed phasic block, independent of holding potential. The recovery time constant from aprindine-induced phasic block was 4.8 s at holding potential = –100 mV and 5.0 s at holding potential = –140 mV. This use-dependent block of aprindine had pH dependency. Under acidic condition (pH 6.0), 3 µmol/l aprindine showed smaller use-dependent block (14% ± 7% at 2 Hz; n = 4) comparing with either at pH 7,4 (68% ± 13%; n = 4) or at pH 8.0 (90% ±12%; n = 4).The results suggest that aprindine could bind to the receptor via activation process through channel pore, resulting in decrease of Na+ current, and egress from the receptor through the lipid bilayer. These effects might be attenuated under acidic condition due to changes in intracellular ratio of charged to neutralized form of drug molecule.
Send offprint requests to: R. Sato at the above address 相似文献
33.
We calculated the standardized mortality ratios (SMRs) of biliary tract cancer (BTC) in Japan from 1981 to 1990 and statistically analyzed the results according to 333 Secondary Areas of Medical Care, as well as sex and subsite [gallbladder cancer (GBC) and extrahepatic bile duct cancer (BDC)], in order to examine geographic clustering patterns of BTC. In GBC in both sexes, the Secondary Areas of Medical Care with high SMRs were clustered in the eastern part of Japan. In BDC in both sexes, the Areas with high SMRs were clustered between the northern and eastern parts of Japan. In comparison with GBC, this clustering favored the northern part of Japan. In males, the clustering pattern in mortality from BTC was mainly due to the occurrence of BDC. In females, the clustering pattern in mortality from BTC reflected that of GBC. The clustering of BTC, especially GBC, seems to be related to the distribution of plains, basins, and rivers. 相似文献
34.
Hiroto Takahashi Mayumi Abe Toshiyuki Sugawara Katsuhiro Tanaka Yasuki Saito Sigefumi Fujimura Masabumi Shibuya Yasufumi Sato 《Cancer science》1998,89(4):445-451
Clotrimazole, an imidazole antimycotic, interferes with the rise in cytosolic Ca2+ and inhibits cell proliferation in a reversible manner. Here we describe the effect of clotrimazole on vascular endothelial cells (ECs). Clotrimazole inhibited the proliferation of ECs stimulated with typical angiogenic growth factors; vascular endothelial growth factor and basic fibroblast growth factor (bFGF). This inhibitory effect of clotrimazole was dose-dependent and the maximal inhibition was observed at a concentration of 10 m M . We did not observe any increase in 51 Cr release from ECs during treatment with 10 μ M . clotrimazole. Moreover, clotrimazole inhibited the basal and bFGF-stimulated migration of ECs. As clotrimazole inhibited two principle components of angiogenesis; the proliferation and migration of ECs, we examined whether clotrimazole inhibited angiogenesis. Tube formation by ECs in type 1 collagen gel was investigated, and clotrimazole was found to be significantly inhibitory. The inhibitory effect of clotrimazole on angiogenesis was further confirmed in an in vivo angiogenesis model of murine Matrigel plug assay. These results demonstrate that clotrimazole is a potent inhibitor of angiogenesis. 相似文献
35.
Severe heart failure (NYHA Class IV) is associated with increased left ventricular mass index and short mitral deceleration time in severe aortic valve stenosis 下载免费PDF全文
Sayuki Kobayashi MD PhD Hiroto Utsunomiya MD PhD Takahiro Shiota MD PhD 《Echocardiography (Mount Kisco, N.Y.)》2018,35(8):1108-1115
36.
37.
38.
39.
Ken Fukunaga Yoshio Ohda Nobuyuki Hida Masaki Iimuro Yoko Yokoyama Koji Kamikozuru Kazuko Nagase Shiro Nakamura Hiroto Miwa Takayuki Matsumoto 《Journal of gastroenterology and hepatology》2012,27(12):1808-1815
Background and Aim: Topical mesalamine or corticosteroid has shown efficacy in patients with ulcerative proctitis, but patients often become refractory to these interventions. Xilei San is a herbal preparation with evidence of anti‐inflammatory effects. We evaluated the efficacy of topical Xilei San in ulcerative proctitis patients. Methods: In a double blind setting, 30 patients with intractable ulcerative proctitis despite ≥ 4 weeks of topical mesalamine or corticosteroid were randomly assigned to True (n = 15) and placebo (n = 15). Patients in True received suppository Xilei San (0.1 g/dose per day of Xilei San), the other 15 received placebo suppository. The initial efficacy was evaluated on day 14. Primary endpoint of the trial was avoiding relapse during 180 days, relapse meant recurrence of active disease. Riley's index was applied for endoscopic and histological evaluations, while patients' quality of life was evaluated by an inflammatory bowel disease questionnaire. Results: On day 14, the number of patients who achieved remission, clinical activity index ≤ 4 in True was significantly higher versus placebo (P < 0.04). Likewise, at day 180, an 81.8% of patients in True were without relapse versus 16.7% in placebo (P < 0.001). Further, significant endoscopic (P < 0.01), histological (P < 0.02) and inflammatory bowel disease questionnaire (P < 0.04) improvements were observed in True, but not in placebo. Conclusions: This is the first controlled investigation showing significant clinical and endoscopic efficacy for Xilei San in patients with intractable ulcerative proctitis. Topical Xilei San was well tolerated, and was without safety concerns. 相似文献